Gene therapy for hemophilia has emerged as a groundbreaking treatment option, offering new hope for individuals battling this lifelong condition.Unlike traditional hemophilia management methods that rely on regular injections of clotting factors, recent advancements, such as the FDA-approved gene therapy Hemgenix, provide a one-time solution that targets the root cause of hemophilia B.